Skip to main content
SpringerLink
Log in

Interferon update

  • Main topic
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Medical Research Council Renal Cancer Collaborators (1999) Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomized controlled trial. Lancet 353:14–17

    Article  Google Scholar 

  2. Pyrhönen S, Salminen E, Ruutu M et al. (1999) Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer. J Clin Oncol 17:2859–2867

    PubMed  Google Scholar 

  3. Kankuri M, Pelliniemi T-T, Pyrhönen S et al. (2001) Feasibility of prolonged use of interferon-α in metastatic kidney carcinoma. Cancer 92:761–767

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest:

No information supplied

Author information

Authors and Affiliations

  1. Department of Oncology and Radiotherapy, Turku University Central Hospital, Turku, Finland

    S. Pyrhönen

  2. Department of Oncology and Radiotherapy, Turku University Central Hospital, Kiinamyllykatu 4–8, SF-20520, Turku, Finland

    S. Pyrhönen

Authors
  1. S. Pyrhönen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Pyrhönen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pyrhönen, S. Interferon update. Urologe 43 (Suppl 3), 137–138 (2004). https://doi.org/10.1007/s00120-004-0604-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-004-0604-8

Keywords

Search

Navigation